Few data points exist for this record so far. The page fills in as further notices are published.
Supplier
ORION Pharma GmbH
Hamburg · DEU
Total awarded
—
2 joint award(s) counted pro rata
Reg. Umsatzsteuer Ident Nr: DE811460900
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| Salmeterol + Fluticason (IHP) | GWQ ServicePlus AG | GlaxoSmithKline GmbH & Co. KG, Glenmark Arzneimittel GmbH, ORION Pharma GmbH | — | 11 Aug 2026 |
| Salmeterol + Fluticason (IHP) | GWQ ServicePlus AG | GlaxoSmithKline GmbH & Co. KG, Glenmark Arzneimittel GmbH, ORION Pharma GmbH | — | 7 Aug 2026 |
| Levosimendan 12,5 mg in 5 ml Konzentrat Infusionslösungskonzentrat St a 5 ml | PBMG eG | ORION Pharma GmbH | — | 2 Mar 2026 |
| Ranibizumab 2,3 mg Injektionslösung Durchstechflasche St | PBMG eG | ORION Pharma GmbH | — | 2 Mar 2026 |
| Budesonid (IHP) | GWQ ServicePlus AG | ORION Pharma GmbH | — | 12 Feb 2026 |
| Formoterol (12 µg; IHP) | GWQ ServicePlus AG | ORION Pharma GmbH, Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg | — | 12 Feb 2026 |
| 152 | Levodopa + Carbidopa + Entacapon Filmtabletten [2] | IKK classic | BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH), ORION Pharma GmbH | €483,544 | 11 Aug 2025 |
| 118 | Formoterol + Budesonid Inhalationspulver [2] | IKK classic | BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft)BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft), ORION Pharma GmbH | €3,268,653 | 11 Aug 2025 |
| 037 | Budesonid Inhalationspulver [1] | IKK classic | ORION Pharma GmbH | €1,195,068 | 11 Aug 2025 |